Letrozole

Letrozole, the active ingredient in Letrozole, is an aromatase inhibitor presented as a tablet for oral use. It treats postmenopausal estrogen receptor‑positive breast cancer and is used in hormone‑related oncology protocols. GNH USA supplies Letrozole as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

GNH USA supplies Letrozole as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

Letrozole acts ​       ​  ​  ​  ​  ​  ​  ​  ​  ​   ​  ​  ​  ​  ​  ​  ​ ​  ​  """""""""""""""""""""""""""""""""""""""""""""""""""""""

- Postmenopausal estrogen‑receptor‑positive breast cancer: Improves survival by reducing the production of estrogen in peripheral tissues . - Early‑stage breast cancer (adjuvant): Supports the benefit of adjutect ‑     ﰜ  ﰬ  

- Ov‑    

-  . -  t